FDA Advisers Back Exact Sciences Colon Cancer Test

FDA Advisers Back Exact Sciences Colon Cancer Test

The FDA's committee of genetic experts voted 10-0 that the benefits of Exact Sciences' Cologuard test outweigh its risks. The vote amounts to a recommendation for the FDA to approve the test from Exact Sciences of Madison, Wis. The agency is not

6
Like
Save

Comments

Write a comment

*